Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A possible interaction between lithium and diltiazem: case report.

E V Valdiserri

    The Journal of Clinical Psychiatry
    |December 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Calcium channel blockers like diltiazem may interact with lithium, a mood stabilizer. This case report highlights a potential synergistic effect between diltiazem and lithium, impacting calcium metabolism.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Understanding depression in schizophrenia.

    Hospital & community psychiatry·1989
    Same author

    Practices reported by incarcerated drug abusers to reduce risk of AIDS.

    Hospital & community psychiatry·1988
    Same author

    A study of offenses committed by psychotic inmates in a county jail.

    Hospital & community psychiatry·1986
    Same author

    Psychiatry behind bars.

    The Bulletin of the American Academy of Psychiatry and the Law·1984
    Same author

    Victims of childhood sexual abuse: a follow-up study of a noncompliant populations.

    Hospital & community psychiatry·1982
    Same author

    Psychotherapeutic issues in a Veterans Administration outpatient clinic.

    American journal of psychotherapy·1982

    Area of Science:

    • Pharmacology
    • Clinical Medicine
    • Neuroscience

    Background:

    • Calcium channel blockers are a novel drug class for angina treatment, functioning by inhibiting calcium ion influx during cellular depolarization.
    • Lithium, a mood-stabilizing agent, shares electrochemical properties with calcium and modulates calcium metabolism and transport pathways.
    • Understanding drug interactions is crucial for patient safety, especially when medications affect similar physiological processes.